Home › Mesothelioma › Pennsylvania
Mesothelioma clinical trials in Pennsylvania
13 studies for Mesothelioma are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07277413A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
- Allegheny Health Network (Data Collection Only), Pittsburgh
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06057935Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
- University of Pennsylvania - Abramson Cancer Center, Philadelphia
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT06566079A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT04104776Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
- AHN West Penn Hospital, Pittsburgh
RecruitingPhase 1
Ages 18 to 79 · All sexes · Updated Aug 4, 2026 · NCT07192900Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- USOR Alliance Cancer Specialist, Doylestown
- Allegheny Health Network, Pittsburgh
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT05579366Lead-212 PSV359 Therapy for Patients With Solid Tumors
- University of Pittsburgh Medical Center, Pittsburgh
RecruitingPhase 1/2
Ages 18 to 90 · All sexes · Updated Jul 6, 2026 · NCT06710756SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
- University of Pennsylvania, Philadelphia
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 24, 2026 · NCT05568680CT-95 in Advanced Cancers Associated With Mesothelin Expression
- University of Pennsylvania, Philadelphia
- Context Investigational Site, Philadelphia
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT06756035A Study of VET3-TGI in Patients With Solid Tumors
- UPMC- Hillman Cancer Center, Pittsburgh
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 7, 2026 · NCT06444815Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors
- AHN West Penn Hospital, Pittsburgh
RecruitingPhase 1
Ages 18 to 79 · All sexes · Updated Apr 7, 2026 · NCT07443020VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Cancer Care Associates of York (site 206), York
RecruitingPhase 1/2
Ages 18 to 80 · All sexes · Updated Dec 11, 2025 · NCT03556228Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Dec 4, 2025 · NCT03760575From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.